Search filters

List of works by Michael A Blazing

A care pathway for the cardiovascular complications of COVID-19: Insights from an institutional response

scientific article published on 03 May 2020

A tale of two trials: a comparison of the post-acute coronary syndrome lipid-lowering trials A to Z and PROVE IT-TIMI 22.

scientific article published on 13 March 2006

Achievement of dual low-density lipoprotein cholesterol and high-sensitivity C-reactive protein targets more frequent with the addition of ezetimibe to simvastatin and associated with better outcomes in IMPROVE-IT.

scientific article published on September 2015

Acute decline in renal function, inflammation, and cardiovascular risk after an acute coronary syndrome

scientific article published on 09 October 2009

An update on the IMProved reduction of outcomes: Vytorin Efficacy International Trial (IMPROVE-IT) design

scientific article published on 15 March 2010

Atherosclerotic disease in non-insulin-dependent diabetes mellitus: role of abnormal lipids and the place for lipid-altering therapies

scientific article

Atherothrombotic Risk Stratification and Ezetimibe for Secondary Prevention

scientific article published in February 2017

Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With Versus Without Diabetes Mellitus: Results From IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial).

scientific article published on 20 December 2017

Benefit of Ezetimibe Added to Simvastatin in Reduced Kidney Function

scientific article published on 15 May 2017

Biomarkers and Clinical Cardiovascular Outcomes With Ezetimibe in the IMPROVE-IT Trial

scientific article published on 01 August 2019

Clinical relevance of C-reactive protein during follow-up of patients with acute coronary syndromes in the Aggrastat-to-Zocor Trial

scientific article published on 17 July 2006

Competing Risks of Cardiovascular Versus Noncardiovascular Death During Long-Term Follow-Up After Acute Coronary Syndromes

scientific article published on 18 September 2017

Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial

scientific article

Effect of Simvastatin-Ezetimibe Compared With Simvastatin Monotherapy After Acute Coronary Syndrome Among Patients 75 Years or Older: A Secondary Analysis of a Randomized Clinical Trial

scientific article published on 17 July 2019

Effect of intensive lipid-lowering therapy on mortality after acute coronary syndrome (a patient-level analysis of the Aggrastat to Zocor and Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 trial

scientific article published on 18 July 2007

Effect of statin dose on incidence of atrial fibrillation: data from the Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22) and Aggrastat to Zocor (A to Z) trials

scientific article

Effect on high-density lipoprotein cholesterol of maximum dose simvastatin and atorvastatin in patients with hypercholesterolemia: results of the Comparative HDL Efficacy and Safety Study (CHESS).

scientific article published in November 2003

Effects of early treatment with statins on short-term clinical outcomes in acute coronary syndromes: a meta-analysis of randomized controlled trials

scientific article published in May 2006

Efficacy and Safety of Adding Ezetimibe to Statin Therapy Among Women and Men: Insight From IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial).

scientific article published on 18 November 2017

Efficacy and bleeding complications among patients randomized to enoxaparin or unfractionated heparin for antithrombin therapy in non-ST-Segment elevation acute coronary syndromes: a systematic overview

scientific article published in July 2004

Efficacy and safety of ezetimibe co-administered with simvastatin compared with atorvastatin in adults with hypercholesterolemia

scientific article

Enoxaparin versus unfractionated heparin in patients treated with tirofiban, aspirin and an early conservative initial management strategy: results from the A phase of the A-to-Z trial

scientific article (publication date: October 2004)

Estimated glomerular filtration rate, inflammation, and cardiovascular events after an acute coronary syndrome

scientific article published on 21 February 2008

Evaluating cardiovascular event reduction with ezetimibe as an adjunct to simvastatin in 18,144 patients after acute coronary syndromes: final baseline characteristics of the IMPROVE-IT study population

scientific article published on 15 May 2014

Evaluation of the National Cholesterol Education Program Adult Treatment Panel III algorithm for selecting candidates for statin therapy: insights from the A to Z trial

scientific article (publication date: 15 September 2006)

Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes

scientific article

Ezetimibe plus a Statin after Acute Coronary Syndromes

scientific article published on 01 October 2015

Impact of Ezetimibe on the Rate of Cardiovascular-Related Hospitalizations and Associated Costs Among Patients With a Recent Acute Coronary Syndrome: Results From the IMPROVE-IT Trial (Improved Reduction of Outcomes: Vytorin Efficacy International T

scientific article published on May 2017

Interpreting the Benefit of Simvastatin-Ezetimibe in Patients 75 Years or Older-Reply

scientific article published on 02 January 2020

Is rhythm-control superior to rate-control in patients with atrial fibrillation and diastolic heart failure?

scientific article published on July 2010

Lipoprotein (a): An Update on a Marker of Residual Risk and Associated Clinical Manifestations

scientific article published on 07 April 2020

Long-term Safety and Efficacy of Achieving Very Low Levels of Low-Density Lipoprotein Cholesterol : A Prespecified Analysis of the IMPROVE-IT Trial

scientific article published on 14 March 2017

Medication Discontinuation in the IMPROVE-IT Trial

scientific article published on 01 January 2019

Muscle Complaints or Events in Patients Randomized to Simvastatin or Ezetimibe/Simvastatin

scientific article published on 01 February 2020

Natural History of Patients Postacute Coronary Syndrome Based on Heart Failure Status

scientific article published on 04 August 2018

On-treatment analysis of the Improved Reduction of Outcomes: Vytorin Efficacy International Trial (IMPROVE-IT).

scientific article published on 23 September 2016

Outcomes of patients with acute coronary syndrome and previous coronary artery bypass grafting (from the Pravastatin or Atorvastatin Evaluation and Infection Therapy [PROVE IT-TIMI 22] and the Aggrastat to Zocor [A to Z] trials).

scientific article published on 12 June 2008

Patient Phenotypes, Cardiovascular Risk, and Ezetimibe Treatment in Patients After Acute Coronary Syndromes (from IMPROVE-IT)

scientific article published on 25 January 2019

Polyvascular disease, type 2 diabetes, and long-term vascular risk: a secondary analysis of the IMPROVE-IT trial

scientific article published on 02 November 2018

Premature release of data from clinical trials of ezetimibe

scientific article

Prevention of Stroke with the Addition of Ezetimibe to Statin Therapy in Patients With Acute Coronary Syndrome in IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial).

scientific article published on 30 September 2017

Prognostic value of anxiety and depression in patients with chronic heart failure

scientific article published on 22 November 2004

Prognostic value of serial B-type natriuretic peptide testing during follow-up of patients with unstable coronary artery disease

scientific article published on December 2005

Rationale and design of IMPROVE-IT (IMProved Reduction of Outcomes: Vytorin Efficacy International Trial): comparison of ezetimbe/simvastatin versus simvastatin monotherapy on cardiovascular outcomes in patients with acute coronary syndromes

scientific article published on 2 September 2008

Reduction in Total Cardiovascular Events With Ezetimibe/Simvastatin Post-Acute Coronary Syndrome: The IMPROVE-IT Trial

scientific article published on February 2016

Relationship of depression to increased risk of mortality and rehospitalization in patients with congestive heart failure

scientific article published in August 2001

Reply: Adding Ezetimibe to Simvastatin for the Secondary Prevention of Cardiovascular Disease: Is it Useful?

scientific article published on 01 June 2016

Reply: Personalize and Optimize Lipid-Lowering Therapies

scientific article published on 01 July 2016

Response to Letter Regarding Article, "Achievement of Dual Low-Density Lipoprotein Cholesterol and High-Sensitivity C-Reactive Protein Targets More Frequent With the Addition of Ezetimibe to Simvastatin and Associated With Better Outcomes in IMPROVE

scientific article published on 01 March 2016

Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis

scientific article

Safety and efficacy of enoxaparin vs unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes who receive tirofiban and aspirin: a randomized controlled trial

scientific article (publication date: 7 July 2004)

Serial measurement of monocyte chemoattractant protein-1 after acute coronary syndromes: results from the A to Z trial

scientific article published on 13 November 2007

Splanchnic nerve block for decompensated chronic heart failure: splanchnic-HF

scientific article published on 01 December 2018

The A-to-Z Trial: Methods and rationale for a single trial investigating combined use of low-molecular-weight heparin with the glycoprotein IIb/IIIa inhibitor tirofiban and defining the efficacy of early aggressive simvastatin therapy

scientific article (publication date: August 2001)

The association between depression and chronic kidney disease and mortality among patients hospitalized with congestive heart failure

scientific article

The benefit of adding ezetimibe to statin therapy in patients with prior coronary artery bypass graft surgery and acute coronary syndrome in the IMPROVE-IT trial

scientific article published on 28 August 2016

The benefit of implementing a heart failure disease management program

scientific article

The nonalcoholic fatty liver disease (NAFLD) fibrosis score, cardiovascular risk stratification and a strategy for secondary prevention with ezetimibe

scientific article published on 26 May 2018

Paulina is supported by:

About Paulina

Help